Gerald McLaughlin

Chief Executive Officer at NEOS THERAPEUTICS, INC.

56 year

Health Technology

Consumer Services

Electronic Technology

Active connections

Name	Gender	Age	Linked companies	Collaboration
Thomas Jensen	M	46	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	20 years
Punit Dhillon	M	44	SKYE BIOSCIENCE, INC.	6 years
Steen Meier Knudsen	M	63	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	20 years
Tristan Edwards	M	49	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	7 years
Laura Benjamin	M	-	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	-
Joseph Vazzano	M	40	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	1 years
Deborah A. Griffin	F	57	NUPATHE INC	10 years
David Sinclair	M	55	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	7 years
Joan Brown	F	71	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	3 years
Mehmood Khan	M	66	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	5 years
Carolyn R. Sikes	M	-	NEOS THERAPEUTICS, INC.	-
Patricia Russo	F	71	MERCK & CO., INC.	29 years
Caroline Litchfield	F	55	MERCK & CO., INC.	34 years
Marie Foegh	M	82	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	6 years
Mark Oki	M	55	NEOS THERAPEUTICS, INC.	-
Bryant Fong	M	51	NEOS THERAPEUTICS, INC.	15 years
Steven A. Klein	M	60	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	-
Brian Patrick Malone	M	-	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	6 years
Margaret Cabano	F	-	NEOS THERAPEUTICS, INC.	19 years
Steven M. Lutz	M	57	NEOS THERAPEUTICS, INC.	-
David Sinclair	M	-	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	7 years
Matthew Corey	M	39	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	-
Ilan Stern	M	-	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	-
Stuart Gibson	M	-	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	-
Bracken Darrell	M	61	Life Biosciences, Inc. Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.	-
Greg Pyszczymuka	M	-	NEOS THERAPEUTICS, INC.	6 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
James Cullem	M	56	ALLARITY THERAPEUTICS, INC. Allarity Therapeutics A/S Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.	4 years
Richard Eisenstadt	M	66	AYTU BIOPHARMA, INC. NEOS THERAPEUTICS, INC.	7 years
Robert P. Luciano	M	-	MERCK & CO., INC.	23 years
Kenneth Frazier	M	69	MERCK & CO., INC.	30 years
P. Vagelos	M	94	MERCK & CO., INC.	19 years
Beth Hecht	F	60	AYTU BIOPHARMA, INC. NEOS THERAPEUTICS, INC.	6 years
David Green	M	61	AYTU BIOPHARMA, INC.	5 years
Jane Hollingsworth	F	66	NUPATHE INC	7 years
Raymond Gilmartin	M	82	MERCK & CO., INC.	2 years
Wayne P. Yetter	M	78	NUPATHE INC	4 years
Joyce N. LaViscount	F	62	Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.	5 years
Keith Goldan	M	52	NUPATHE INC	6 years
Michael Cola	M	64	NUPATHE INC	8 years
Vipin K. Garg	M	67	NEOS THERAPEUTICS, INC.	5 years
Richard S. Egosi	M	61	NUPATHE INC	-
Søren Jensen	M	61	ALLARITY THERAPEUTICS, INC.	2 years
Gail Maderis	F	66	ALLARITY THERAPEUTICS, INC.	2 years
Laura Sepp-Lorenzino	M	63	MERCK & CO., INC.	15 years
Ezra Felker	M	54	NUPATHE INC	7 years
Larry G. Edwards	M	52	MERCK & CO., INC.	15 years
Russell McMahen	M	-	NEOS THERAPEUTICS, INC.	-
David Roth	M	61	ALLARITY THERAPEUTICS, INC.	1 years
Mike Diem	M	54	NUPATHE INC	-
James Robinson	M	54	NEOS THERAPEUTICS, INC.	2 years
Robert Oliver	M	65	ALLARITY THERAPEUTICS, INC.	-
Charles Rowland	M	65	Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.	2 years
John B. Hollister	M	62	SKYE BIOSCIENCE, INC.	1 years
Marino Carol	F	-	MERCK & CO., INC.	8 years
Joseph Romanelli	M	50	MERCK & CO., INC.	19 years
John M. Limongelli	M	54	NEOS THERAPEUTICS, INC.	2 years
Linda Szyper	F	58	NEOS THERAPEUTICS, INC.	3 years
David Gionco	M	63	MERCK & CO., INC.	3 years
Michael Marino	M	48	NUPATHE INC	4 years
Ketan B. Mehta	M	62	AYTU BIOPHARMA, INC.	3 years
John Schmid	M	61	NEOS THERAPEUTICS, INC.	6 years
Christopher Brooke	M	-	AYTU BIOPHARMA, INC.	2 years
Gary Kurtzman	M	69	NUPATHE INC	6 years
Thomas Shenk	M	77	MERCK & CO., INC.	11 years
Jim Datin	M	61	NUPATHE INC	2 years
William Harrison	M	80	MERCK & CO., INC.	-
Anne Tatlock	F	84	MERCK & CO., INC.	-
Brian J. Sisko	M	64	NUPATHE INC	2 years
Armando Anido	M	66	NUPATHE INC	2 years
Robert P. Roche	M	68	NUPATHE INC	4 years
Thomas George	M	68	SKYE BIOSCIENCE, INC.	3 years
Donald S. Brooks	M	88	MERCK & CO., INC.	-
Douglas Ingram	M	61	SKYE BIOSCIENCE, INC.	3 years
Richard Markham	M	73	MERCK & CO., INC.	20 years
Wendy Yarno	F	68	MERCK & CO., INC.	9 years
William Federici	M	64	NUPATHE INC	3 years
Greg J. Robitaille	M	60	NEOS THERAPEUTICS, INC.	12 years
Roland Gerritsen van der Hoop	M	-	Endo Pharmaceuticals, Inc. Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.	-
Duncan Moore	M	65	ALLARITY THERAPEUTICS, INC.	2 years
Alan L. Heller	M	70	NEOS THERAPEUTICS, INC.	12 years
Jeanne Cunicelli	F	57	NUPATHE INC	6 years
Richard Kollender	M	54	NUPATHE INC	2 years
Simon Benito	M	79	MERCK & CO., INC.	25 years
Silvana Battaglia	F	56	MERCK & CO., INC.	10 years
Nolan Sigal	M	73	MERCK & CO., INC.	10 years
Timothy Proctor	M	74	MERCK & CO., INC.	13 years
Mark E. McDonough	M	59	MERCK & CO., INC.	-
Ray Hill	M	79	MERCK & CO., INC.	18 years
Robert W. Verdugo	M	-	MERCK & CO., INC.	3 years
Dorothy P. Bowers	F	-	MERCK & CO., INC.	-
Barry Gumbiner	M	68	MERCK & CO., INC.	6 years
Carole A. Sable	M	62	MERCK & CO., INC.	12 years
Douglas J. MacMaster	M	93	MERCK & CO., INC.	31 years
Misti Ushio	M	53	MERCK & CO., INC.	10 years
Vijay Samant	M	77	MERCK & CO., INC.	23 years
Jeffrey A. Peris	M	77	MERCK & CO., INC.	25 years
Bernard J. Kelley	M	82	MERCK & CO., INC.	10 years
Alan Nies	M	86	MERCK & CO., INC.	10 years
Susan Molineaux	M	70	MERCK & CO., INC.	5 years
John W. Gillard	M	-	MERCK & CO., INC.	11 years

Statistics

Country	Connections	% of total
United States	100	100.00%
Denmark	7	7.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections